We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Advertising
We regulate advertisements for therapeutic goods. You need to know if that includes the product you intend to advertise.
Last updated
-
Advertising basics
Information about what is considered advertising, if advertising is allowed for your product and using the Advertising Code. -
Applying the Advertising Code
The Therapeutic Goods (Therapeutic Goods Advertising Code) Instrument 2021 (the Code) outlines requirements when advertising to the general public. -
Specialised advertising issues and topics
Explore advertising information on specific topics, such as social media and goods like Ozempic. Find out ways to promote health services offering products that cannot be advertised to the public. -
Understanding social media advertising rules
Find out how therapeutic goods legislation applies to social media posts, comments, hashtags, and paid promotions. Includes practical resources for businesses, influencers and consumers. -
Advertising legal framework
Information on the legal and regulatory framework underpinning our rules on advertising therapeutic goods. -
Advertising consultations
Find information on consultations and the Therapeutic Goods Advertising Consultative Committee (TGACC).
Compliance
-
Compliance and enforcement
We monitor and enforce compliance with laws that regulate health products. -
Advertising compliance and reports
How we manage advertising compliance, and where to find information about enforcement outcomes.
Latest alerts
-
TGA is issuing a safety advisory about the importation of unregistered GLP-1 products that are being promoted online for weight-loss.
-
Weleda Australia Pty Ltd is recalling one batch of Weleda Baby Teething Powder following a complaint that a fragment of glass was found in one bottle of this product.
-
We are aware of products being sold in Australia that claim to contain, or influence the levels of, nicotinamide adenine dinucleotide (NAD, NAD+, NADH) or nicotinamide mononucleotide (NMN) in the body.
Latest articles
-
TGA releases updated social media advertising guidance to support improved compliance
The TGA has updated its Advertising therapeutic goods on social media guidance to help advertisers to understand their responsibilities when promoting therapeutic goods via these platforms. -
ACPharm Queensland issued infringement notices for alleged unlawful advertising of therapeutic goods
We have issued 5 infringement notices, totalling $99,000, to ACPharm Queensland Pty Ltd (ACPharm Queensland) for the alleged unlawful advertising of therapeutic goods. -
Enforceable direction: Hwangbo SS Pty Ltd and [REDACTED]
The delegate believes, on reasonable grounds, that it is in the interests of public health or safety to give Hwangbo SS Pty Ltd and [REDACTED] directions under section 42YT of the Therapeutic Goods Act 1989.
Latest publications
-
Communique from the meeting of the TGACC
-
This plan outlines our compliance and education priorities for 2024-2025.
-
Communique from the meeting of the TGACC